Literature DB >> 16929069

Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration.

C H Meyer, S Mennel, J C Schmidt, P Kroll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929069      PMCID: PMC1857397          DOI: 10.1136/bjo.2006.093732

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.

Authors:  F Gelisken; W Inhoffen; M Partsch; U Schneider; I Kreissig
Journal:  Am J Ophthalmol       Date:  2001-04       Impact factor: 5.258

2.  Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; Andrew A Moshfeghi; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2005 Jul-Aug

3.  Which treatment is best for which AMD patient?

Authors:  P Kroll; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 4.  [Tissue-type plasminogen activator. An enzyme with multiple uses in ophthalmology].

Authors:  L Hesse
Journal:  Ophthalmologe       Date:  1997-05       Impact factor: 1.059

5.  Retinal pigment epithelial tear with vitreomacular attachment: a novel pathogenic feature.

Authors:  C H Meyer; C A Toth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-06       Impact factor: 3.117

6.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

  6 in total
  28 in total

1.  [Effect of intravitreal bevacizumab on pigment epithelial detachment in occult choroidal neovascularization].

Authors:  M Ruppenstein; T Ach; A Höh; S Dithmar
Journal:  Ophthalmologe       Date:  2010-09       Impact factor: 1.059

2.  Intravitreally administered bevacizumab (Avastin) in minimally classic and occult choroidal neovascularization secondary to age-related macular degeneration.

Authors:  Ratimir Lazic; Nikica Gabric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-11-18       Impact factor: 3.117

3.  Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone.

Authors:  Ilse Krebs; Katharina Krepler; Ulrike Stolba; Alexandra Goll; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-03       Impact factor: 3.117

4.  Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.

Authors:  Gary K Y Lee; Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.117

Review 5.  [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors:  C H Meyer; F Ziemssen; H Heimann
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

6.  Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors:  David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

7.  Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis).

Authors:  Clement K Chan; Atul Jain; Srinivas Sadda; Neeta Varshney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

8.  Intravitreal bevacizumab: an analysis of the evidence.

Authors:  Derrick P Smit; David Meyer
Journal:  Clin Ophthalmol       Date:  2007-09

9.  Retinal detachment with macular hole following combined photodynamic therapy and intravitreal bevacizumab injection.

Authors:  Eun Jee Chung; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2007-09

10.  Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration.

Authors:  Saad Shaikh; John C Olson; Preston P Richmond
Journal:  Indian J Ophthalmol       Date:  2007 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.